Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mayne Pharma rockets 79pc on takeover bid; Chalmers aims to cut red tape on tax; Gilbert + Tobin private equity partner resigns
Want to get this in your inbox at lunchtime every weekday? Financial Review subscribers can sign up for The Brief newsletter here. Plus start your day with our Before the Bell newsletter and read a full wrap of the day's news in Market Wrap. In…
DRI search at Cipla involving imported pharma product
Updated - November 17, 2026 at 12:56 PM. | Mumbai Drugmaker Cipla said that the Directorate of Revenue Intelligence (Mumbai zonal unit) had conducted a search at its office in Vikhroli, Mumbai, and at its depot in Bhiwandi, Thane. The search on…
AstraZeneca Pharma India inks agreement with Strand Life Sciences to explore healthcare collaboration
Updated - November 17, 2026 at 04:13 PM. | New Delhi, Nov 17 AstraZeneca Pharma India Ltd on Tuesday said it has signed a letter of intent (LoI) with Strand Life Sciences Pvt Ltd to explore opportunities to collaborate in healthcare in India.
NewAmsterdam Pharma Sees Unusually Large Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) saw some unusual options trading on Tuesday. Traders acquired 7,505 call options on the company. This is an increase of approximately 962% compared to the typical volume of 707 call…
NewAmsterdam Pharma Sees Unusually High Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 7,505 call options on the company. This is an increase of 962% compared to the typical volume of 707…
Avalyn Pharma (NASDAQ:AVLN) Stock Falls 8.1% Following Analyst Downgrade
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) traded down 8.1% on Tuesday after Morgan Stanley lowered their price target on the stock from $57.00 to $53.00. Morgan Stanley currently has an overweight rating on the stock. Avalyn Pharma traded…
Teachers Retirement System of The State of Kentucky Buys 415,100 Shares of Royalty Pharma PLC $RPRX
Teachers Retirement System of The State of Kentucky acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired…
PJP: Healthcare Sector Dashboard For November
The healthcare equipment industry is undervalued based on historical averages, while pharma/biotechnology is significantly overvalued. Invesco Pharmaceuticals ETF (PJP) offers multi-factor pharmaceutical exposure suited to long-term and tactical…
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials. The funding was co-led by Greenoaks and…
PwC's IPO Lead On A Selective Market, AI Valuations And The Outlook For 2027
The U.S. IPO market has rebounded, but the recovery remains uneven. Companies seeking to go public face investors focused on durable revenue, profitability and valuation, while uncertainty has prompted some issuers to postpone their offerings. Mike…
Immunome: De-Risked With The FDA, With An Admirably Deep Clinical Bench
I maintain a Buy on Immunome, Inc.: its $2.1 billion market cap leaves upside versus the Springworks acquisition valuation. Varegacestat's phase 3 progression-free survival hazard ratio was 0.16; the FDA decision is due April 28, 2027, though…
Turning Scientific Breakthroughs In CGT Into Patient Benefits
Kimberley Barnes is President of Phacilitate, uniting the global advanced therapies ecosystem. From targeting and modifying cancer cells to treating genetic disorders, cell and gene therapies (CGT) promise health outcomes once…
Swiss patients face unequal access to life-saving treatment
After a long legal battle with the Federal Office of Public Health (FOPH), RTS obtained data behind a 2020 government-commissioned report that showed huge disparities in insurance coverage of new treatments. The investigationExternal link by RTS…
Investors look to Nvidia's earnings and Anthropic's IPO to refresh the tech rally
Defensive stocks like Big Pharma have taken the lead from imploding chip stocks, but these stocks lack the heft to carry a bull market. Can Nvidia's results on Tuesday and Anthropic's IPO refresh the tech bid? Twenty years ago this week, my 'Death…
Guilt continues' for families harmed by sodium valproate scandal
'Even though I know it's not my fault, the guilt continues and I don't think it will ever go away.' Emma Friedmann's son Andrew is one of an estimated 20,000 children in UK believed to have been harmed by the epilepsy drug sodium valproate since it…
Receive a Daily briefing on Pharma Industry News
Get Started